In Brief: Aloe vera
This article was originally published in The Tan Sheet
Executive Summary
Aloe vera: FDA sets Aug. 30 "OTC feedback" meeting with International Aloe Science Council, Inc. to discuss recent scientific studies on aloe, focusing on its therapeutic effects. The council also plans to update FDA on efforts to develop an identity standard for aloe vera as well as address biological claims for inclusion in the OTC monograph. The group also will provide safety data...